·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥, ¾àÇйڻç Ãëµæ ±â»çÀÔ·Â : 23.02.22 14:42:58 1 °¡ ÇÃÄ£Ãß°¡ ¾ÆÁÖ´ëÇб³·ÎºÎÅÍ ¾àÇÐ ¹Ú»çÇÐÀ§ ¼ö¿© [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥°¡ ¾ÆÁÖ´ë·ÎºÎÅÍ ¾àÇÐ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇß´Ù. ° ´ëÇ¥´Â Çѱ¹À¯³ªÀÌƼµåÁ¦¾à â¾÷ÁÖ °´ö¿µ ´ëÇ¥ Àå³²ÀÌ´Ù. ° ´ëÇ¥´Â 22ÀÏ ¾ÆÁÖ´ëÇб³¿¡¼ ¿¸° 2022Çг⵵ Àü±â ¾àÇдëÇÐ ÇÐÀ§¼ö¿©½Ä¿¡¼ ¾àÇÐ ¹Ú»çÇÐÀ§¸¦ ¼ö¿©¹Þ¾Ò´Ù. ° ´ëÇ¥´Â "¾ÕÀ¸·Î Çѱ¹À¯³ªÀÌƼµåÁ¦¾àÀÇ ¹ßÀü¿¡ ´õ Å©°Ô ±â¿©ÇÏ°Ú´Ù"°í ¸»Çß´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ÀǾàÇ° µµ¸Å»ó KGSPÇ°Áú°ü¸®¾à»ç´Ô ¸ðÁý ¹Ù·Î°¡±â ¼¿ïÁö¹æ±³Á¤Ã» ÀϹÝÁ÷°ø¹«¿ø(¾à¹«ÁÖ»ç) °æ·Â°æÀïä¿ë½ÃÇè °ø°í ¹Ù·Î°¡±â R&DºÎ¼ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼¿ïÁö»ç) ¹Ù·Î°¡±â Medical Information Associate ¹Ù·Î°¡±â Áö¿¤Æĸ¶ °³¹ßº»ºÎ_»ç¾÷°³¹ßÆÀ, °³¹ßÆÀ ä¿ë °ø°í ¹Ù·Î°¡±â [Çѵ¶] MI ¸Å´ÏÀú/°Ç°±â´É½ÄÇ° ¿¬±¸¿ø/¸¶ÄÉÆÃ/µðÁöÅÐÇコÄÉ¾î ¿µ¾÷/IVD ¿µ¾÷/RA/Corporate Development/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â ¾ÆÁÖ´ë ¤» µÎ ±³¼ö´Ô.. ȸÀå´Ô Á¹¾÷»çÁøÀε¥ Á» ´ÙÁ¤ÇÏ°Ô Æ÷Áî ÃëÇϽÃÁö.. 23.02.22 22:41:21 0 ¼öÁ¤ »èÁ¦ 0 0 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥, ¾àÇйڻç Ãëµæ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥, ¾àÇйڻç Ãëµæ ±â»çÀÔ·Â : 23.02.22 14:42:58 1 °¡ ÇÃÄ£Ãß°¡ ¾ÆÁÖ´ëÇб³·ÎºÎÅÍ ¾àÇÐ ¹Ú»çÇÐÀ§ ¼ö¿© [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥°¡ ¾ÆÁÖ´ë·ÎºÎÅÍ ¾àÇÐ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇß´Ù. ° ´ëÇ¥´Â Çѱ¹À¯³ªÀÌƼµåÁ¦¾à â¾÷ÁÖ °´ö¿µ ´ëÇ¥ Àå³²ÀÌ´Ù. ° ´ëÇ¥´Â 22ÀÏ ¾ÆÁÖ´ëÇб³¿¡¼ ¿¸° 2022Çг⵵ Àü±â ¾àÇдëÇÐ ÇÐÀ§¼ö¿©½Ä¿¡¼ ¾àÇÐ ¹Ú»çÇÐÀ§¸¦ ¼ö¿©¹Þ¾Ò´Ù. ° ´ëÇ¥´Â "¾ÕÀ¸·Î Çѱ¹À¯³ªÀÌƼµåÁ¦¾àÀÇ ¹ßÀü¿¡ ´õ Å©°Ô ±â¿©ÇÏ°Ú´Ù"°í ¸»Çß´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç ÀǾàÇ° µµ¸Å»ó KGSPÇ°Áú°ü¸®¾à»ç´Ô ¸ðÁý ¹Ù·Î°¡±â ¼¿ïÁö¹æ±³Á¤Ã» ÀϹÝÁ÷°ø¹«¿ø(¾à¹«ÁÖ»ç) °æ·Â°æÀïä¿ë½ÃÇè °ø°í ¹Ù·Î°¡±â R&DºÎ¼ °æ·ÂÁ÷ ¾à»ç¸ðÁý (¼¿ïÁö»ç) ¹Ù·Î°¡±â Medical Information Associate ¹Ù·Î°¡±â Áö¿¤Æĸ¶ °³¹ßº»ºÎ_»ç¾÷°³¹ßÆÀ, °³¹ßÆÀ ä¿ë °ø°í ¹Ù·Î°¡±â [Çѵ¶] MI ¸Å´ÏÀú/°Ç°±â´É½ÄÇ° ¿¬±¸¿ø/¸¶ÄÉÆÃ/µðÁöÅÐÇコÄÉ¾î ¿µ¾÷/IVD ¿µ¾÷/RA/Corporate Development/HSE ÆÀÀå/IT º¸¾È ´ã´ç/°ü¸®¾à»ç ¹Ù·Î°¡±â ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â °Ç°±â´É½ÄÇ° ¾à±¹À¯Åë ÀÚ¹®/Çмú ¾à»ç ¸ðÁý ¹Ù·Î°¡±â Çѱ¹¾Ï¿þÀÌ R&D ºÎ¼ Technical Regulatory Analystä¿ë ¹Ù·Î°¡±â ¾ÆÁÖ´ë ¤» µÎ ±³¼ö´Ô.. ȸÀå´Ô Á¹¾÷»çÁøÀε¥ Á» ´ÙÁ¤ÇÏ°Ô Æ÷Áî ÃëÇϽÃÁö.. 23.02.22 22:41:21 0 ¼öÁ¤ »èÁ¦ 0 0 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥, ¾àÇйڻç Ãëµæ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥, ¾àÇйڻç Ãëµæ ±â»çÀÔ·Â : 23.02.22 14:42:58 1 °¡ ÇÃÄ£Ãß°¡ ¾ÆÁÖ´ëÇб³·ÎºÎÅÍ ¾àÇÐ ¹Ú»çÇÐÀ§ ¼ö¿© [µ¥Àϸ®ÆÊ=À̼®ÁØ ±âÀÚ] °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥°¡ ¾ÆÁÖ´ë·ÎºÎÅÍ ¾àÇÐ ¹Ú»çÇÐÀ§¸¦ ÃëµæÇß´Ù. ° ´ëÇ¥´Â Çѱ¹À¯³ªÀÌƼµåÁ¦¾à â¾÷ÁÖ °´ö¿µ ´ëÇ¥ Àå³²ÀÌ´Ù. ° ´ëÇ¥´Â 22ÀÏ ¾ÆÁÖ´ëÇб³¿¡¼ ¿¸° 2022Çг⵵ Àü±â ¾àÇдëÇÐ ÇÐÀ§¼ö¿©½Ä¿¡¼ ¾àÇÐ ¹Ú»çÇÐÀ§¸¦ ¼ö¿©¹Þ¾Ò´Ù. ° ´ëÇ¥´Â "¾ÕÀ¸·Î Çѱ¹À¯³ªÀÌƼµåÁ¦¾àÀÇ ¹ßÀü¿¡ ´õ Å©°Ô ±â¿©ÇÏ°Ú´Ù"°í ¸»Çß´Ù. À̼®ÁØ ±âÀÚ(wiviwivi@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
¾ÆÁÖ´ë ¤» µÎ ±³¼ö´Ô.. ȸÀå´Ô Á¹¾÷»çÁøÀε¥ Á» ´ÙÁ¤ÇÏ°Ô Æ÷Áî ÃëÇϽÃÁö.. 23.02.22 22:41:21 0 ¼öÁ¤ »èÁ¦ 0 0 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2024,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : °¿øÈ£ Çѱ¹À¯³ªÀÌƼµåÁ¦¾à ´ëÇ¥, ¾àÇйڻç Ãëµæ URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö